Polycythemia vera is a rare blood cancer that makes the body produce too many red blood cells. Many people with polycythemia vera are older adults, and the early symptoms of polycythemia vera can include headaches, dizziness, itching after a warm bath or shower, and unusual tiredness. Not everyone will have the same experience. Polycythemia vera is usually a long-term condition, and without treatment it can raise the risk of blood clots, stroke, heart attack, and in some cases more serious bone marrow disease. Treatment often helps people manage polycythemia vera for many years and may include regular blood removal, low-dose aspirin, and medicines to lower blood counts.
How many people live with Polycythemia vera?
Polycythemia vera is rare, and there is no single worldwide head count, but Orphanet estimates it affects about 1 to 5 people out of every 10,000, which suggests roughly 800,000 to 4 million people may be living with it worldwide, depending on how cases are diagnosed and counted (Orphanet, 2024). In the United States, about 100,000 people are estimated to be living with polycythemia vera (Leukemia & Lymphoma Society, 2024).
Overview
Polycythemia veraSymptoms
Polycythemia vera often causes headaches, dizziness, itching after a warm bath, tiredness, and blurred vision. Some people with polycythemia vera also notice redness, burning pain in the hands or feet, or blood clot symptoms.
Outlook and prognosis
Many people with polycythemia vera live for years or decades with treatment and regular blood checks. The outlook is often good, especially when it is found early. Care mainly aims to lower the risk of blood clots and, over time, other bone marrow problems.
Causes and risk factors
Polycythemia vera is usually linked to an acquired change in the JAK2 gene that develops over time, not something caused by lifestyle. Risk rises with older age, and rarely, inherited factors may increase susceptibility.
Genetic influences
Genetics are very important in Polycythemia vera. Most people have an acquired JAK2 gene change that drives the disease, while inherited genetic factors usually play a much smaller role.
Diagnosis
Polycythemia vera is usually diagnosed with blood tests that show too many red blood cells. Doctors often check erythropoietin levels and look for a JAK2 gene change. Sometimes a bone marrow biopsy helps confirm the diagnosis of polycythemia vera.
Treatment and drugs
Polycythemia vera is usually managed by lowering thick blood and reducing clot risk, often with regular blood draws and low-dose aspirin. Some people with polycythemia vera also need medicines that slow blood cell production or ease symptoms like itching.
Symptoms
Polycythemia vera often shows up through symptoms caused by blood becoming thicker and moving less easily through the body. At first, you may just feel more tired than usual, get headaches, or itch intensely after a warm shower; these can be some of the early symptoms of polycythemia vera. The changes are often subtle at first, blending into daily life until they become more noticeable. Some people have very few symptoms, while others notice problems with concentration, circulation, or a sense of fullness in the belly.
Thicker blood can make blood flow less smoothly, which may lead to frequent headaches, lightheadedness, or feeling off balance. Some people notice this more in warm rooms or when they stand up quickly.
Intense itching, especially after a warm bath or shower, is a classic symptom of polycythemia vera. The skin may look normal, but the itch can be strong enough to interrupt sleep or make it hard to relax.
Many people with polycythemia vera feel unusually tired, even after enough rest. Everyday tasks like climbing stairs, exercising, or getting through a workday may take more effort than before.
Blurry vision, seeing spots, or brief episodes of dim vision can happen when small blood vessels are affected. Some may also notice ringing in the ears or a heavy, pressured feeling in the head.
How people usually first notice Polycythemia vera?
For many people, polycythemia vera first shows up quietly, with symptoms that are easy to brush off: unusual tiredness, headaches, dizziness, blurry vision, ringing in the ears, or intense itching after a warm shower or bath. Some living with polycythemia vera first notice a flushed or ruddy face, burning pain or redness in the hands or feet, or a feeling of fullness on the left side of the belly if the spleen is enlarged. In quite a few cases, though, the first warning sign is not a symptom at all but an abnormal blood test showing too many red blood cells, sometimes after a routine checkup or after a blood clot prompts medical attention.
Types of Polycythemia vera
Polycythemia vera can affect daily life in different ways, from headaches and itching to unusual tiredness or a feeling of fullness after small meals. It can be helpful to think of symptoms in categories. There are no formal disease subtypes used in everyday care, but the main symptom patterns can help explain the early symptoms of polycythemia vera and how they may differ from one person to another.
Blood thickness
Some people with polycythemia vera mainly notice problems linked to thicker blood, such as headaches, dizziness, blurred vision, or ringing in the ears. Warmth, redness, or a burning feeling in the hands or feet can also happen. These symptoms may flare when blood counts rise.
Itching symptoms
Others are most bothered by itching, especially after a warm bath or shower. This itching can be intense even when the skin looks normal. For many living with polycythemia vera, this becomes one of the most disruptive symptom patterns.
Clotting signs
In some cases, the first clues are related to blood clots rather than day-to-day discomfort. This can mean pain and swelling in a leg, chest pain, shortness of breath, or sudden neurologic symptoms that need urgent care. These symptoms are less common than headache or itching, but they are more serious.
Bleeding problems
Even though clotting is a major concern, some may bruise easily or have nosebleeds or bleeding gums. This can happen because blood cells are not working normally. Bleeding symptoms should also be discussed promptly with a healthcare provider.
Enlarged spleen
Many with polycythemia vera develop an enlarged spleen, which can cause pressure or pain under the left ribs. Some feel full quickly when eating, even after a small meal. This pattern may become more noticeable over time.
General symptoms
Some people mainly feel tired, weak, sweaty at night, or generally unwell. Weight loss can happen, but it is not present in everyone. Symptoms don’t always look the same for everyone.
Can I slow down the onset of symptoms?
No, there is no proven lifestyle change or medical treatment that clearly delays the start of symptoms in polycythemia vera, because it begins with changes in the blood-making cells in the bone marrow. Healthy habits like not smoking and taking care of blood pressure, cholesterol, weight, sleep, and activity may still help lower the risk of blood clots and other problems, but that is not the same as preventing the disease or stopping it from starting. If polycythemia vera is diagnosed, early regular treatment to keep the blood from getting too thick can help control symptoms and reduce complications, and while it cannot promise a delayed course, staying engaged with care can still make a meaningful difference.
What genetics can tell you about symptoms
Genetics can explain part of why polycythemia vera shows up differently from one person to another, but it does not let doctors predict every symptom with certainty. Most people with this condition have a change in a gene called JAK2, which helps drive the overproduction of blood cells, and research suggests that the exact genetic pattern may influence how strongly someone tends to develop features such as high blood counts, itching, blood clots, an enlarged spleen, or symptoms that appear earlier or later in life. Even so, symptoms are also shaped by age, overall health, and other non-genetic factors, so genetics is one piece of the picture rather than a full forecast.
Causes and risk factors
If you are being checked for headaches, itching after a warm shower, or a high blood count, the main cause of polycythemia vera is usually a JAK2 gene change that develops during life. This change is usually not inherited, though family history may slightly raise risk in some people. Polycythemia vera is more common in older adults and a little more common in men. Doctors distinguish between risk factors for polycythemia vera that you can change and those you can’t. No single environmental trigger explains most cases, though very high radiation exposure has been studied and smoking can add to blood clot risk.
What are the most common causes or risk factors?
Polycythemia vera is usually caused by a change that develops over time in the blood-making cells in the bone marrow, most often in a gene called JAK2, which makes the body produce too many red blood cells; this change is usually not inherited from a parent. It becomes more common with older age, is seen a little more often in men, and a family history of this disease or a related blood disorder may slightly raise risk, although many people with polycythemia vera have no clear outside cause.
Environmental and biological risk factors
Polycythemia vera is most often diagnosed later in adulthood, and the strongest risks come from changes inside the bone marrow rather than from anything you did. Doctors often group risks into internal (biological) and external (environmental). When people ask who gets polycythemia vera, the clearest patterns are older age, male sex, and an acquired change in blood-forming cells, while only a few outside exposures have been linked with confidence.
Polycythemia vera becomes more common as people get older, especially after age 60. It is uncommon in younger adults and rare in children.
Polycythemia vera is diagnosed somewhat more often in men than in women. This is a pattern seen in large groups, not something that guarantees a person will develop the condition.
Nearly all people with polycythemia vera have an acquired change in a blood-forming bone marrow cell, most often involving JAK2. This change happens after birth rather than being inherited, and it pushes the marrow to make too many blood cells.
High-dose ionizing radiation has been linked to some bone marrow disorders and may raise the chance of polycythemia vera, although this link is less certain than the biological factors above. Many living with polycythemia vera have no known radiation exposure.
Genetic risk factors
Understanding the genetic risk factors for polycythemia vera starts with one key point: the main change usually develops over time in blood-forming cells, rather than being present from birth. Most people with polycythemia vera have a change in a gene called JAK2, which helps control how many blood cells the bone marrow makes. Some risk factors are inherited through our genes. In practice, family history can matter, but polycythemia vera is usually not passed directly from parent to child.
JAK2 V617F: This is the most common gene change linked to polycythemia vera and is found in most people with the condition. It keeps growth signals switched on, so the bone marrow makes too many blood cells.
Exon 12 change: A smaller group of people with polycythemia vera have a different JAK2 change, often called an exon 12 mutation. It can also drive too much red blood cell production, even when JAK2 V617F is not present.
Acquired change: In most cases, the JAK2 change is acquired, meaning it appears in marrow cells during life rather than being inherited. This helps explain why many people with polycythemia vera have no known family history.
Family history: Having a close relative with polycythemia vera or a related bone marrow disorder can slightly raise risk. This probably reflects inherited DNA patterns that make certain gene changes more likely, but the disease still remains uncommon.
Familial tendency: Rarely, polycythemia vera clusters in families. This suggests there can be an inherited tendency in some households, even though no single inherited cause explains most cases.
Lifestyle risk factors
For polycythemia vera, no lifestyle habit is known to be a primary cause, but daily habits can still affect symptoms and the risk of serious complications such as blood clots. When people ask about lifestyle risk factors for polycythemia vera, the main issues are behaviors that thicken the blood further, reduce circulation, or add cardiovascular strain. Exercise, hydration, smoking status, alcohol use, and overall heart health are the most relevant areas.
Smoking damages blood vessels and makes blood more likely to clot, which adds to one of the biggest risks in polycythemia vera. It can also worsen headaches, dizziness, and shortness of breath by reducing oxygen delivery.
Not drinking enough fluids can concentrate the blood and make sluggish circulation worse in polycythemia vera. Good hydration may help limit symptom flares and may support safer blood flow, especially in hot weather or during illness.
Long periods of sitting and very low physical activity can slow blood flow and increase clot risk, especially in the legs. Regular movement and appropriate exercise can improve circulation, energy, and cardiovascular fitness.
Carrying excess body weight raises the risk of high blood pressure, sleep apnea, and vascular disease, all of which can compound complications in polycythemia vera. A heart-healthy eating pattern may help reduce overall strain on the circulation.
Risk prevention
There is no proven way to prevent polycythemia vera itself, because it usually develops from changes in bone marrow cells that are not something you can control. For many living with polycythemia vera, prevention is mainly about lowering the risk of blood clots, bleeding, and other complications. Prevention works best when combined with regular check-ups.
Following your treatment plan, including blood draws or medicines if prescribed, helps keep red blood cell levels from getting too high. This can lower the risk of clotting problems linked to polycythemia vera.
Smoking can further thicken the blood's effects on circulation and raises the chance of heart attack, stroke, and blood clots. Quitting is one of the most important risk-reducing steps for people with polycythemia vera.
Drinking enough fluids helps support healthy blood flow, especially during hot weather, illness, or long travel days. Dehydration can make circulation sluggish and may worsen headache, dizziness, or clot risk.
Regular walking and leg movement help blood circulate better and may lower clot risk, especially on flights or car rides lasting several hours. Many with polycythemia vera may also benefit from avoiding long stretches of sitting still.
Can you prevent Polycythemia vera?
No, there is no proven way to prevent polycythemia vera. It usually develops because of changes that happen over time in the blood-making cells in the bone marrow, and these changes are not something you can control. Healthy habits are still important for overall health, but they have not been shown to stop polycythemia vera from starting.
Transmission
Polycythemia vera is not infectious or contagious, so it cannot be caught from someone through coughing, kissing, sex, or everyday contact. It is also not usually passed directly from parent to child, because in most people with Polycythemia vera the gene change starts later in life in blood-forming cells in the bone marrow rather than being present at birth.
When people ask about how Polycythemia vera is inherited, the short answer is that most cases are not inherited at all. A small number of families seem to have a higher tendency to develop Polycythemia vera or related blood disorders, but this is uncommon.
When to test your genes
Consider gene testing if blood work shows persistently high hemoglobin or hematocrit, especially with low erythropoietin, unexplained blood clots, itching after warm water, or an enlarged spleen. In polycythemia vera, testing for a JAK2 mutation helps confirm the diagnosis and can guide monitoring and treatment choices.
Diagnosis
Polycythemia vera is usually diagnosed after routine blood work or symptoms raise concern, such as headaches, unusual itching after a warm shower, dizziness, or feeling unusually tired. It’s natural to worry when symptoms don’t have a clear explanation. Doctors confirm the diagnosis of polycythemia vera by looking at blood counts, checking for a common gene change, and making sure another cause is not explaining the higher blood cell levels.
A complete blood count measures red blood cells, hemoglobin, and hematocrit, and it often shows levels that are higher than expected in polycythemia vera. White blood cells and platelets may also be increased, which can give doctors an important early clue.
Doctors ask about symptoms such as headaches, blurred vision, ringing in the ears, night sweats, and itching, especially after bathing. They also look for smoking, lung disease, dehydration, sleep apnea, or medicines that could raise blood counts for other reasons.
Most people with polycythemia vera have a change in the JAK2 gene, which can be found with a blood test. This is a key part of how polycythemia vera is diagnosed because it helps separate it from many secondary causes of high red blood cells.
Doctors often check the erythropoietin, or EPO, level in the blood. In polycythemia vera, this level is often low because the body is not simply reacting to a need for more oxygen.
How is Polycythemia vera diagnosed?
Polycythemia vera is usually diagnosed with blood tests that show too many red blood cells, and often higher levels of other blood cells as well. Doctors also look for a very common gene change called JAK2 and may check the level of a hormone that normally tells the body to make red blood cells, which is often low in this condition. In some cases, they also take a small bone marrow sample from inside a bone to confirm the diagnosis and rule out other blood disorders.
Stages of Polycythemia vera
Polycythemia vera can move through recognized phases over time, although not everyone goes through all of them. Early on, changes may be picked up on blood tests before day-to-day symptoms are obvious, while later phases can affect energy, comfort, and blood flow more clearly. The process can involve several steps, each one adding to the picture.
Early phase
Blood cell levels start to rise, sometimes before clear symptoms appear. The early symptoms of polycythemia vera can be easy to miss, such as headaches, tiredness, or itching after a warm shower.
Overt phase
Too many red blood cells are present, and many people with polycythemia vera begin to notice more symptoms in daily life. This can include flushing, dizziness, blurred vision, burning pain in the hands or feet, or blood clots.
Spent phase
In some people, the bone marrow gradually becomes scarred and less able to make healthy blood cells. This later phase, called post-polycythemia vera myelofibrosis, can lead to worsening fatigue, weight loss, night sweats, anemia, and an enlarged spleen.
Blast phase
Rarely, polycythemia vera changes into a fast-growing blood cancer similar to acute leukemia. This is the most serious phase and can cause severe weakness, infections, bleeding, and a rapid decline in health.
Outlook and prognosis
The outlook for people with polycythemia vera has improved substantially, and many now live for years to decades with careful monitoring and treatment. Prognosis varies with age, prior blood clots, blood counts, cardiovascular risk factors, and whether the disease responds well to therapies such as phlebotomy, low-dose aspirin, and cytoreductive medication. The main long-term risks are thrombosis and bleeding, and a smaller proportion of patients develop myelofibrosis or acute myeloid leukemia over time. Modern studies suggest median survival is often well over 10 years and can approach 20 years or more in lower-risk patients, although outcomes are generally shorter in older adults and those with high-risk disease features. Mortality is most often related to thrombotic events, disease progression, treatment complications, or other age-related illnesses rather than uncontrolled blood counts alone. Regular follow-up and good control of cardiovascular risks can meaningfully improve both quality of life and overall survival.
Long-term effects
Polycythemia vera can affect health over many years because the bone marrow keeps making too many blood cells, which makes the blood thicker and harder to move smoothly. For many, symptoms can stay fairly stable for a long time, while others develop more noticeable complications over time. The long-term picture is often shaped by blood clots, bleeding problems, an enlarged spleen, and in some people, changes in the bone marrow itself.
Thickened blood can raise the risk of clots in the legs, lungs, heart, or brain. Over time, this can lead to problems such as stroke, heart attack, or a deep vein clot, sometimes even in people whose early symptoms of polycythemia vera seemed mild.
Even though the blood is thicker, some people with polycythemia vera bruise easily or have nosebleeds, gum bleeding, or heavier bleeding than expected. This can happen because blood cell levels become unbalanced and platelets may not work normally.
The spleen may grow larger as it helps filter extra blood cells. For many living with polycythemia vera, this can mean fullness after small meals, pressure under the left ribs, or ongoing discomfort in the upper belly.
Long-term effects can involve tiredness, headaches, dizziness, night sweats, itching after a warm bath or shower, and trouble concentrating. Many people notice small adjustments—like needing more rest or pacing daily tasks—because these symptoms can come and go for years.
How is it to live with Polycythemia vera?
Living with polycythemia vera often means paying attention to a body that can feel unexpectedly heavy or off balance: many people live well for years, but day to day they may deal with fatigue, headaches, dizziness, itching after a warm shower, or a sense of fullness from an enlarged spleen. Daily life can also include regular blood tests, clinic visits, and treatments such as blood draws or medicines to lower the risk of blood clots, so routines may need a little more planning around energy, hydration, and follow-up care. For family and other close people, the main impact is usually practical and emotional rather than contagious risk; they may help with appointments, watch for warning signs like chest pain or sudden weakness, and adjust to the fact that some days look completely normal while others do not.
Treatment and drugs
Polycythemia vera is treated by lowering the number of red blood cells and reducing the risk of blood clots, which can help with symptoms such as headaches, dizziness, itching after a warm shower, or unusual tiredness. For many people, treatment begins with small daily steps: regular blood removal, called phlebotomy, works a bit like donating blood and helps bring the blood thickness down. Many living with polycythemia vera also take low-dose aspirin, and some need medicines that slow blood cell production in the bone marrow, especially if they are older, have had a clot before, or still have symptoms despite phlebotomy. Doctors also look after related issues such as high uric acid, troublesome itching, or an enlarged spleen, and they may suggest staying active, not smoking, and keeping blood pressure, cholesterol, and diabetes well controlled. Not every treatment works the same way for every person, so follow-up visits and blood tests are an important part of treatment for polycythemia vera.
Can you cure Polycythemia vera?
For most people, polycythemia vera cannot be cured. Treatment can still help a lot by lowering the number of blood cells, easing symptoms, and reducing the risk of blood clots and other problems. In rare cases, a stem cell transplant may offer a cure, but it is only used for some people because it carries serious risks.
Non-drug treatment
Living with polycythemia vera often means dealing with fatigue, headaches, itching, or a heavy, sluggish feeling that can make ordinary days harder. Alongside medicines, non-drug therapies play a big part in care by lowering the risk of blood clots, easing symptoms, and helping you stay active safely. For many, treatment begins not at the pharmacy, but with regular blood removal, healthy daily habits, and close follow-up. These steps can also help when early symptoms of polycythemia vera are mild but persistent.
Regular blood draws are a main non-drug treatment for polycythemia vera. Removing some blood lowers the number of red blood cells and helps the blood flow more easily. This can reduce clot risk and may ease symptoms like headache, dizziness, or pressure in the head.
Drinking enough fluids helps prevent dehydration, which can make the blood more concentrated. Many living with polycythemia vera may find this especially helpful in hot weather, during exercise, or with illness that causes fluid loss.
Regular walking, light exercise, and avoiding long stretches of sitting can support circulation and lower clot risk. Some strategies can slip naturally into your routine—like standing up on long car rides or flights and moving your legs every hour.
Cool or lukewarm showers, gentle skin care, and fragrance-free moisturizers can help with the itching that many people with polycythemia vera notice after bathing. Hot water often makes this worse, so keeping baths and showers cooler may bring relief.
Your genes may have an impact on how drugs work for you
In polycythemia vera, the main genetic change that helps cause the disease can also shape how active the illness is, so some people respond better than others to treatments used to lower blood counts or calm an overactive bone marrow. For example, many living with polycythemia vera do well with medicines that slow blood cell production, while others may need a different approach if their counts stay high, symptoms continue, or side effects become a problem. Even so, for this condition, doctors usually do not rely on special drug-gene matching tests to choose treatment, and instead adjust care based on blood tests, symptoms, and how the disease behaves over time.
Pharmacological treatments
Treatment for polycythemia vera often focuses on lowering the risk of blood clots, bringing blood counts down, and easing symptoms such as itching or fullness from an enlarged spleen. The drugs used depend on age, clotting history, symptoms, and how high the blood counts are. There is no single best medication for polycythemia vera for everyone, and not everyone responds to the same medication in the same way. Many people with polycythemia vera also have blood removed regularly, but the medicines below are the main drug options.
Low-dose aspirin is commonly used in polycythemia vera to make platelets less sticky and lower the chance of dangerous blood clots. It is often used unless there is a strong reason to avoid it, such as active bleeding, some stomach ulcers, or certain bleeding disorders.
Hydroxyurea is a common first-choice medicine to lower high red blood cell counts, and it can also reduce platelets and white blood cells when they are too high. Many living with polycythemia vera take it long term when clot risk is higher, but regular blood tests are needed to watch for low counts and other side effects.
Interferon alfa, including peginterferon alfa-2a and ropeginterferon alfa-2b, helps the bone marrow slow down blood cell production. It may be a good option for younger adults, for some during pregnancy planning, or when hydroxyurea is not a good fit, though flu-like symptoms or mood changes can occur in some people.
Ruxolitinib is used when polycythemia vera is not well controlled with hydroxyurea or when side effects make hydroxyurea hard to continue. It can help lower blood counts, reduce spleen size, and improve symptoms such as itching, night sweats, and abdominal discomfort.
Genetic influences
Most people with polycythemia vera have a change in the JAK2 gene in the blood-forming cells in their bone marrow, and that change pushes the body to make too many blood cells. These gene changes are usually acquired during life rather than inherited from a parent, so polycythemia vera does not usually run strongly in families. Many people ask whether polycythemia vera is hereditary, and in most cases the main mutation happens after birth, although close relatives may have a slightly higher chance of developing polycythemia vera or a related blood disorder. Rarely, inherited genetic factors may make someone more likely to develop this condition, but they are not the direct cause in the way a single-gene disorder works. Having a genetic risk is not the same as having the disease itself. If doctors suspect polycythemia vera, they often use blood tests and JAK2 testing to help confirm the diagnosis and guide treatment.
Is Polycythemia vera genetic?
Genetics are very important in Polycythemia vera. Most people have an acquired JAK2 gene change that drives the disease, while inherited genetic factors usually play a much smaller role.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are commonly found across the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, having a variant linked to a condition suggests a possible association, not a definite diagnosis, especially when several genes and environmental factors are involved. Still, in some cases, one well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with polycythemia vera, treatment decisions are shaped partly by the gene change driving the disease, most often a change called JAK2. Doctors can use your genetic information to help confirm the diagnosis and, in some cases, guide drug choice. Because this gene change keeps blood-cell production switched on, medicines that block this pathway, such as ruxolitinib, can help when polycythemia vera is not well controlled with standard treatment or when other drugs are hard to tolerate. This is one reason the genetics of polycythemia vera matter not just for diagnosis, but also for treatment.
At the same time, genetics is only part of the picture. For many, treatment is still based mainly on everyday factors such as age, blood counts, clotting risk, symptoms, and how well current therapy is working. Other gene changes may affect how the condition behaves over time, but they do not yet guide routine drug treatment for most people with polycythemia vera.
Interactions with other conditions
People living with polycythemia vera may find that other health problems, especially heart and blood vessel disease, can raise the risk of complications such as blood clots, stroke, or heart attack. If someone also has high blood pressure, diabetes, high cholesterol, or smokes, the blood-thickening effect of polycythemia vera can become more concerning in day-to-day care. Doctors call it a comorbidity when two conditions occur together. Polycythemia vera can also overlap with gout, because higher cell turnover may increase uric acid and trigger sudden joint pain, often in the big toe. Some people with polycythemia vera develop an enlarged spleen, and if liver disease or another blood disorder is also present, symptoms like fullness after small meals, tiredness, or abdominal discomfort may be harder to sort out. Over time, a small number of people can develop other blood cancers, so regular follow-up matters, especially if new symptoms such as worsening fatigue, easy bruising, frequent infections, or night sweats appear.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Polycythemia vera?
Yes. Polycythemia vera can look like other causes of a high red blood cell count, especially dehydration, smoking, long-term lung or heart disease, sleep apnea, or living at high altitude, because these can also lead to headaches, dizziness, tiredness, and shortness of breath. It can also be confused with other blood and bone marrow disorders that make too many blood cells, so doctors often use blood tests and sometimes genetic testing to tell them apart.
History
Long before blood tests were available, doctors described people who looked unusually flushed, had frequent headaches, dizziness, or troubling itching after a warm bath. What we now call polycythemia vera was first recognized through these everyday patterns rather than through lab science, and early reports focused on the effects it had on daily life rather than on what was happening in the bone marrow.
In the late 19th century, physicians began linking this cluster of symptoms to blood that was thicker than usual because the body was making too many red blood cells. Once considered rare, now recognized as a long-term blood cancer, polycythemia vera was gradually separated from other conditions that can also raise the red blood cell count, such as dehydration or low oxygen levels. As medical science evolved, doctors also learned that some people with polycythemia vera develop blood clots, an enlarged spleen, or later changes in the bone marrow, which helped define the condition more clearly.
The 20th century brought more reliable blood counts and bone marrow testing, so diagnosis became much more accurate. Over time, researchers realized that polycythemia vera does not look exactly the same in everyone. Some people are diagnosed after early symptoms of polycythemia vera such as tiredness, headaches, or itching, while others find out only after a routine blood test shows unusually high levels.
More recently, researchers identified a genetic cause in most cases, which helped explain why the bone marrow keeps making too many blood cells. That discovery did not change the day-to-day experience overnight, but it did improve diagnosis and led to more targeted treatment approaches. Knowing the history of polycythemia vera helps make sense of why older descriptions can seem confusing: doctors were observing the same illness, but the tools to name it accurately came much later.